Rachel Lowe will be speaking on the panel “Upcoming USDA Bioengineered Food Regulations” at the 2018 Food Advertising, Labeling, and Litigation Conference: For the Food and Dietary Supplement Industries sponsored by the Food and Drug Law Institute (FDLI).
In May of this year, USDA proposed a rule that would implement a National Bioengineered Food Disclosure Standard (BFDS). This standard includes definitions of “bioengineered food,” sets forth the nature of required disclosures, proposes levels of exception for small amounts of bioengineered ingredients, and proposes three different new graphic symbols that could be used on packaging to indicate the presence of bioengineered ingredients. If the proposed rule is finalized, what impact would it have on food litigation? False-advertising disputes?
For more information, click here.